A Phase III Long-Term Extension Trial With Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants With Major Depressive Disorder (EXTEND)
Phase: PHASE3 | Sponsor: Cybin IRL Limited | Compound: Psychedelic
- Status
- recruiting
- Institution
- Cybin IRL Limited
- Start date
- 2025-07-18
- End date
- 2028-03-15
- Registry ID
- NCT06605105
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.